Brent Burger

Brent Burger has extensive experience in the field of biostatistics and programming. Brent is currently working as the Head of Biostatistics and Programming at UroGen Pharma. Prior to their current role, Brent held the position of Senior Director, Biostatistics at Jazz Pharmaceuticals from November 2020 to November 2022. Brent also served as the Director of Biostatistics at Parexel from October 2014 to March 2019, and as the Director of Biostatistics at Cytel from July 2008 to November 2013. Brent's career in biostatistics began at Sanofi, where they worked as a Manager of Biostatistics from August 1998 to June 2008.

Brent Burger has pursued higher education in various fields. Brent has earned a Master of Science degree in Applied Statistics from Louisiana State University. Additionally, they hold a Master of Science degree in Bioscience Regulatory Affairs from The Johns Hopkins University. Furthermore, Brent has a Master's degree in Business Administration and Management, with a focus on General Management, from Rochester Institute of Technology. Lastly, they obtained a Bachelor of Business Administration degree in Economics from the University of New Orleans.